From: A glance on the role of actin in osteogenic and adipogenic differentiation of mesenchymal stem cells
Chemical | Dose and duration | Osteogenic/adipogenic marker | References |
---|---|---|---|
Cytochalasin D | 0.1 μg/mL for 48 h | ALP and calcium levels decreased at days 5 and 10 | [29] |
Cytochalasin D | 100 ng/mL for 1, 3, 7, and 14 days | Decreased levels of ALP and osteocalcin, increased levels of adiponectin and peroxisome proliferator-activated receptor gamma (PPARG) | [16] |
Cytochalasin D | 0.02 mg/mL | Increased adipogenesis | [83] |
Cytochalasin D | 1–20 μM, 1 h every day for 9 days | Decreased osteoblast differentiation, decreased ALP and mineral matrix | [55] |
Phalloidin | 0–6 μM, 3 h every day for 9 days | Increased ALP activity and mineralized matrix formation |  |
Cytochalasin D | 0.1 mg/mL day 1 | Osterix, osteocalcin, and Runt-related transcription factor 2 (RUNX2) levels increased on days 2 and 3 | [84] |
Cytochalasin D | 0.1 mg/mL for 3 days | Increase in osteogenesis (higher level of alkaline phosphatase, tissue-nonspecific isozyme (Alpl), specificity protein (Sp7), gamma-carboxyglutamic acid-containing protein (Bglap genes)) and adipogenesis (higher level of fatty acid-binding protein (FABP4), adiponectin gene (ADIPOQ), and peroxisome proliferator-activated receptor γ (PPARγ genes)) in growth medium, increased adipogenesis in adipogenic medium, and increases osteogenesis in osteogenic medium | [57] |
Cytochalasin D | 0.1 mg/mL for 14 days | Increase in osteogenesis through increased expression of the VGLL4 gene; the effect of cytochalasin D was dependent on the biological state of the cells | [85] |
Cytochalasin D | 1–20 μM for 1 h every day for 13 days | Increased adipocyte differentiation | [49] |
Phalloidin | 0–3 μM for 3 h every day for 13 days | Decreased adipocyte differentiation and adipocyte-specific gene expression (ADIPOQ, LPL, PPARG, FABP4) | [49] |
Cytochalasin D | – | Increased adipogenesis through the regulation of the FGF2, TGFβ2, EGR2, MEF2D, and IRS1 genes | [56] |